Skip to content

The safety and efficacy of transvaginal colon cancer radical resection

The safety and efficacy of transvaginal colon cancer radical resection

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028205
Enrollment
Unknown
Registered
2019-12-15
Start date
2019-12-19
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Right colon cancer

Interventions

Transvaginal surgery group:Surgical operation of right colon resection and anastomosis via vaginal route10

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients can choose to enter an observational study when they meet all of the following conditions: a) Age: 48-80 years old, or those who are expected to survive naturally for more than 3 years; b) Gender: female; c) Qualitative diagnosis: preoperative biopsy and pathology confirmed colorectal adenocarcinoma or colon adenoma and high-grade intraepithelial neoplasia requiring surgery; d) Localized diagnosis: the tumor is located from the cecum to the sigmoid colon; e) Thoracic and abdominal pelvic plain scan and enhanced CT except distant organ metastasis; f) ASA scores I-III; g) The patient or family member understands the study protocol and is willing to participate in the study, providing written informed consent.

Exclusion criteria

Exclusion criteria: Patients cannot be selected for clinical research when any of the following conditions are present: a) History of previous uterine and vaginal surgery; b) Those with distant organ metastases found by preoperative imaging examination or intraoperative exploration; c) Patients whose CT tumor diameter exceeds 5 cm or lymph node enlargement at the third station before surgery; d) Women of childbearing age with fertility needs in the last 3 years; e) Patients or family members cannot understand the conditions and goals of this study.

Design outcomes

Primary

MeasureTime frame
Excellent rate of postoperative specimen quality;

Countries

China

Contacts

Public ContactYi Xiao

Peking Union Medical College Hospital

xiaoy@pumch.cn+86 13366036387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026